NCT03727243View on ClinicalTrials.gov

Molecular Diagnosis and Risk Stratification of Sepsis in India

UnknownOBSERVATIONAL
Enrollment

550

Participants

Timeline

Start Date

December 6, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

June 11, 2021

Conditions
SepsisSeptic ShockSepsis Syndrome
Trial Locations (1)

576104

RECRUITING

Kasturba Hospital, Kasturba Medical College (KMC), Manipal Academy of Higher Education (MAHE), Udupi

Sponsors
All Listed Sponsors
collaborator

Kasturba Medical College

OTHER

collaborator

BioMérieux

INDUSTRY

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

NCT03727243 - Molecular Diagnosis and Risk Stratification of Sepsis in India | Biotech Hunter | Biotech Hunter